Daphne Vassiliou

Publications
CV
Public outreach and news

Articles

Article: JOURNAL OF INHERITED METABOLIC DISEASE. 2023;46(6):1186-1194
Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case-control study of 188 patients
Lissing M; Wester A; Vassiliou D; Floderus Y; Harper P; Sardh E; Wahlin S
Article: JOURNAL OF INHERITED METABOLIC DISEASE. 2023;46(4):675-686
Maternal and fetal outcomes in acute hepatic porphyria: A Swedish National Cohort Study
Mantel A; Vassiliou D; Lissing M; Stephansson O; Wahlin S; Sardh E
Article: JOURNAL OF INHERITED METABOLIC DISEASE. 2023;46(2):286-299
Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals
Lissing M; Vassiliou D; Floderus Y; Harper P; Yan J; Hagstrom H; Sardh E; Wahlin S
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s530
FRI275 Cancer risk in acute hepatic porphyria: a nationwide matched cohort study in 1, 245 individuals
Lissing M; Vassiliou D; Floderus Y; Yan J; Hagström H; Sardh E; Wahlin S
Article: JOURNAL OF INTERNAL MEDICINE. 2022;291(6):824-836
Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals
Lissing M; Vassiliou D; Floderus Y; Harper P; Bottai M; Kotopouli M; Hagstrom H; Sardh E; Wahlin S
Article: JOURNAL OF INTERNAL MEDICINE. 2022;291(1):81-94
Acute hepatic porphyria and maternal health: Clinical and biochemical follow-up of 44 pregnancies
Vassiliou D; Sardh E
Article: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2021;110(5):1250-1260
A Drug-Drug Interaction Study Evaluating the Effect of Givosiran, a Small Interfering Ribonucleic Acid, on Cytochrome P450 Activity in the Liver
Vassiliou D; Sardh E; Harper P; Simon AR; Clausen VA; Najafian N; Robbie GJ; Agarwal S
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2021;100(9):1712-1721
Treatment with assisted reproduction technologies in women with acute hepatic porphyria
Vassiliou D; Hirschberg AL; Sardh E
Article: GENOME MEDICINE. 2021;13(1):40
Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients
Stranneheim H; Lagerstedt-Robinson K; Magnusson M; Kvarnung M; Nilsson D; Lesko N; Engvall M; Anderlid B-M; Arnell H; Johansson CB; Barbaro M; Bjorck E; Bruhn H; Eisfeldt J; Freyer C; Grigelioniene G; Gustavsson P; Hammarsjo A; Hellstrom-Pigg M; Iwarsson E; Jemt A; Laaksonen M; Enoksson SL; Malmgren H; Naess K; Nordenskjold M; Oscarson M; Pettersson M; Rasi C; Rosenbaum A; Sahlin E; Sardh E; Stodberg T; Tesi B; Tham E; Thonberg H; Tohonen V; von Dobeln U; Vassiliou D; Vonlanthen S; Wikstrom A-C; Wincent J; Winqvist O; Wredenberg A; Ygberg S; Zetterstrom RH; Marits P; Soller MJ; Nordgren A; Wirta V; Lindstrand A; Wedell A
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s63
AS086 Primary liver cancer in acute hepatic porphyria: a national cohort study
Lissing M; Vassiliou D; Floderus Y; Harper P; Bottai M; Kotopouli M; Hagström H; Sardh E; Wahlin S
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2020;382(24):2289-2301
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria
Balwani M; Sardh E; Ventura P; Peiro PA; Rees DC; Stoelzel U; Bissell DM; Bonkovsky HL; Windyga J; Anderson KE; Parker C; Silver SM; Keel SB; Wang J-D; Stein PE; Harper P; Vassiliou D; Wang B; Phillips J; Ivanova A; Langendonk JG; Kauppinen R; Minder E; Horie Y; Penz C; Chen J; Liu S; Ko JJ; Sweetser MT; Garg P; Vaishnaw A; Kim JB; Simon AR; Gouya L
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2019;380(6):549-558
Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria
Sardh E; Harper P; Balwani M; Stein P; Rees D; Bissell DM; Desnick R; Parker C; Phillips J; Bonkovsky HL; Vassiliou D; Penz C; Chan-Daniels A; He Q; Querbes W; Fitzgerald K; Kim JB; Garg P; Vaishnaw A; Simon AR; Anderson KE
Article: LAKARTIDNINGEN. 2016;113:DSHI
[Hereditary metabolic diseases with onset in adulthood. Early and correct treatment of acute symptoms can be life-saving].
Oscarson M; Vassiliou D; Nordenström A; Nergårdh R; Wedell A; von Döbeln U
Article: MEDICAL EDUCATION. 2012;46(4):417-425
Integrating virtual patients into courses: follow-up seminars and perceived benefit
Edelbring S; Brostrom O; Henriksson P; Vassiliou D; Spaak J; Dahlgren LO; Fors U; Zary N
Article: CLINICAL AND EXPERIMENTAL METASTASIS. 2011;28(1):65-73
Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease
Zenger S; He W; Ek-Rylander B; Vassiliou D; Wedin R; Bauer H; Andersson G
Article: CLINICAL AND EXPERIMENTAL METASTASIS. 2003;20(5):437-444
Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma
Carlinfante G; Vassiliou D; Svensson O; Wendel M; Heinegård D; Andersson G

All other publications

Thesis / dissertation: 2023
Studies on the acute porphyrias : with special reference to women’s health
Vassiliou, Daphne
Editorial comment: CANCERS. 2023;15(3):795
Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review
Lissing M; Vassiliou D; Harper P; Sardh E; Wahlin S
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S530
Cancer risk in acute hepatic porphyria: a nationwide matched cohort study in 1, 245 individuals
Lissing M; Vassiliou D; Floderus Y; Yan J; Hagstrom H; Sardh E; Wahlin S
Letter: JOURNAL OF INTERNAL MEDICINE. 2021;290(4):928-930
Homocysteine elevation in givosiran treatment: Suggested ALAS1 siRNA effect on cystathionine beta-synthase
Vassiliou D; Sardh E
Other: CLINICAL CASE REPORTS. 2020;8(12):2483-2487
Challenges in the management of acute intermittent porphyria with recurrent attacks during pregnancy: A case report
Vassiliou D; Lempessi C; Harper P; Sardh E
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S63
Primary liver cancer in acute hepatic porphyria: a national cohort study
Lissing M; Vassiliou D; Floderus Y; Harper P; Bottai M; Kotopouli M; Hagstrom H; Sardh E; Wahlin S
Conference publication: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2020;107:S59
A DRUG-DRUG INTERACTION STUDY INVESTIGATING THE EFFECT OF GIVOSIRAN ON ACTIVITY OF FIVE DRUG METABOLIZING CYP450 ENZYMES IN ACUTE HEPATIC PORPHYRIA (AHP) PATIENTS.
Agarwal S; Sardh E; Harper P; Vassiliou D; Simon A; Robbie G
Conference publication: HEPATOLOGY. 2019;70:100A-101A
ENVISION, A PHASE 3 STUDY OF SAFETY AND EFFICACY OF GIVOSIRAN, AN INVESTIGATIONAL RNAi THERAPEUTIC, IN ACUTE HEPATIC PORPHYRIA PATIENTS
Bissell DM; Gouya L; Balwani M; Rees D; Stein P; Stolzel U; Peiro PA; Bonkovsky HL; Keel S; Park C; Phillips J; Silver S; Windyga J; D'Avola D; Ross G; Stewart P; Ritchie B; Oh J; Harper P; Wang J-D; Langendonk J; Ivanova AVS; Horie Y; Anderson KE; Ventura P; Cappellini MD; Vassiliou D; Monroy S; Petrides P; Adachi T; Kuter D; Scalera S; Penz C; Liu G; Simon A; Ko J; Sardh E

Employments

Affiliated to Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, 2024-2027

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Molecular Medicine and Surgery, Karolinska Institutet, 2024
University Medical Degree, Karolinska Institutet, 2000

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI